Suit Against BD Alleges Antitrust Violations

Becton Dickinson, the world's largest manufacturer of hypodermic needles, has been sued in federal court by a medical clinic accusing it of using its size to stamp out competition and overcharge for its products. The suit charges BD with violating federal antitrust laws through various illegal business practices to maintain a near monopoly in the hypodermics market, reports the Record of Hackensack, NJ.

April 11, 2007

1 Min Read
Suit Against BD Alleges Antitrust Violations

The suit was filed by the International Multiple Sclerosis Management Practice, based in New York City, and it seeks class action status. BD in 2004 paid $100 million to a competitor to settle charges of violating antitrust laws. A BD spokeswoman said the company believes it has broken no laws this time, and will fight the suit.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like